Rituximab in Membranous Nephropathy

NCT00425217 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Membranous Nephropathy

Interventions

DRUG: Rituximab

Sponsor

Mayo Clinic

Collaborators

[object Object]